Solution conformational study of nociceptin and its 1 - 13 and 1 - 11 fragments using circular dichroism and two-dimensional NMR conjunction with theoretical conformational analysis

Journal of Peptide Science

Volumn 10, Issue 11, 2004, Pages 678-690

  Klaudel, Lidia ^a   Łegowska, Anna ^a   Brzozowski, Krzysztof ^a   Silberring, Jerzy ^b   Wójcik, Jacek ^c   Rolka, Krzysztof ^a  

^a UNIVERSITY OF GDA SK   (Poland)

^b JAGIELLONIAN UNIVERSITY   (Poland)

^c INSTITUTE OF BIOCHEMISTRY AND BIOPHYSICS   (Poland)

Author keywords

CD spectroscopy; Conformational studies; Fragments; NMR spectroscopy; Nociceptin

Indexed keywords

AMINO ACID; DIMETHYL SULFOXIDE; NOCICEPTIN; PEPTIDE FRAGMENT; PROTON; WATER;

ALPHA HELIX; ARTICLE; CALCULATION; CIRCULAR DICHROISM; CLINICAL PROTOCOL; COMPUTER PROGRAM; CONTROLLED STUDY; ELECTRIC FIELD; ELECTRICITY; HYDROPHOBICITY; MONTE CARLO METHOD; NUCLEAR MAGNETIC RESONANCE; PEPTIDE ANALYSIS; PEPTIDE SYNTHESIS; PRIORITY JOURNAL; PROTEIN CONFORMATION; PROTEIN STRUCTURE; SIMULATION; STATISTICAL ANALYSIS; THEORETICAL STUDY;

ANIMALS; CIRCULAR DICHROISM; HUMANS; MODELS, MOLECULAR; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; OPIOID PEPTIDES; PEPTIDE FRAGMENTS; PROTEIN CONFORMATION; PROTEIN STRUCTURE, SECONDARY; SOLUTIONS;

EID: 8744299657     PISSN: 10752617     EISSN: None     Source Type: Journal    
DOI: 10.1002/psc.576     Document Type: Article

References (40)

1. Reinscheid RK, Nothecher HP, Bourson A, Ardoti A, Henningen RA, Bunzow JR, Grandy DK, Langen H, Mousma F, Civelli O. Orphanin FQ: a neuropeptide that activates an opioid like G protein-coupled receptor. Science 1995; 270: 792-794.
2. Meunier JC, Mollereau C, Toll L, Snaudeau C, Morisand C, Alvinerie P, Butour JC, Guillemat JC, Ferrara P, Monsarrat B, Mozargull H, Vassart G, Parmetier M, Constentin J. Isolation and structure of the endogenous agonist of opioid receptor-like ORL1 receptor. Nature 1995; 377: 532-535.
3. Suder P, Kotlińska J, Smoluch M, Silberring J, Sallberg M. Metabolic fate of nociceptin/orphanin FQ in the rat spinal cord and biological activity of its released fragment. Peptides 1999; 20: 239-247.
4. Salvadori S, Picone D, Tancredi T, Guerrini R, Spadaccini R, Lazarus LH, Regoli D, Temussi PA. Solution conformation of nociceptin. Biochem. Biophys. Res. Commun. 1997; 233: 640-643.
5. Spadaccini R, Crescenzi O, Picone D, Tancredi T, Temussi PA. Solution structure of dynorphin A (1 - 17): a NMR study in a cryoprotective solvent mixture at 278K. J. Peptide Sci. 1999; 5 306-312.
6. Amodeo P, Guerrini R, Picone D, Salvadori S, Spadaccini R, Tancredi T, Temussi PA. Solution structure of nociceptin peptides. J. Peptide Sci. 2002; 8: 497-509.
7. Guerrini R, Calo G, Rizzi A, Bianchi C, Lazarus L, Salvadori S, Temussi PA, Regoli D. Address and message sequences for the nociceptin receptor: a structure-activity study of nociceptin-(1-13)-peptide amide. J. Med. Chem. 1997; 40: 1789-1793.
8. Salvadori S, Guerrini R, Calo G, Regoli D. Structure-activity studies on nociceptin/orphanin FQ: from full agonist, to partial agonist, to pure antagonist. Il Farmaco 1999; 54: 810-825.
9. Suder P, Kotlińska J, Łȩgowska A, Smoluch M, Hö hne G, Chervet J-P, Rolka K. Silberring J. Determination of nociceptin-orphanin FQ metabolites by capillary LC-MS. Brain Res. Prot 2000: 6: 40-46.
10. Bax A, Davis DG. MLEV-17 based two-dimensional homonuclear magnetization transfer spectroscopy. J. Magn. Reson. 1985; 65 355-360.
11. Piantini U, Sørensen OW, Ernst RR. Multiple quantum filter for elucidating NMR coupling networks. J. Am. Chem. Soc. 1982; 104: 6800-6801.
12. 1H NMR spectra of proteins via double quantum filtering. Biochem. Biophys. Res. Commun. 1983; 117: 479-485.
13. Jeener J, Meier BH, Bachmann P, Ernst RR. Investigation of exchange process by two-dimensional NMR spectroscopy. J. Chem Phys. 1979; 71: 4546-4563.
14. Bodenhausen G, Kogler H, Ernst RR. Selection of coherence-transfer pathways in pulse NMR experiments. J. Magn. Reson. 1984; 58: 370-388.
15. Bothner-By AA, Stephens RL, Lee J-M, Warren CD, Jeanloz RW. Structure determination of a tetrasaccharide: Transient nuclear Overhauser effects in the rotating frame. J. Am. Chem. Soc. 1984; 106: 811-813.
16. Bax A, Davis DG. Practical aspects of two-dimensional transverse NOE spectroscopy. J. Magn. Reson. 1985; 63: 207-213.
17. Bartels CT, Billeter M, Güntert P, Wüthrich K. The program XEASY for the computer-supported NMR spectral analysis of biological macromolecules. J. Biomol. NMR 1995; 6: 1-10.
18. MestRe-C Version 2.3 - Magnetic Resonance Companion. Departamento de Quimica Organica, Facultad de Quimica, Universidad de Santiago de Compostela, Santiago de Compostela, Spain; http://qobrue.usc.es/jsgroup/MestRe-C/MestRe-C.html.
19. Güntert P, Wüthrich K. Efficient computation of three dimensional protein structures in solution form nuclear magnetic resonance data using the program DIANA and the supporting programs CALIBA, HABAS and GLOMSA. J. Mol. Biol. 1991; 217: 517-530.
20. Ripoll DR, Scheraga HA. On the multiple-minima problem in the conformational analysis of polypeptides, II. An electronically driven Monte Carlo method - tests on poly(L-alanine). Biopolymers 1988; 27: 1283-1303.
21. Némethy G, Gibson KD, Palmer KA, Yoon CN, Paterlini G, Zagari A, Rumsey S, Scheraga HA. Energy parameters in polypeptides. 10. Improved geometrical parameters and nonbonded interactions for use in the ECEPP/3 algorithm with application to proline-containing peptides. J. Phys. Chem. 1992; 96: 6472-6484.
22. Groth M, Malicka J, Rodziewicz- Motowidlo S, Czaplewski C, Klaudel L, Wiczk W, Liwo A. Determination of conformational equilibrium of peptides in solution by NMR spectroscopy and theoretical conformational analysis: application to the calibration of mean-field solvation models. Biopolymers 2001; 60: 79-95.
23. Pearlman DA, Case JW, Caldwell JW, Ross WS, Cheatham TE, Ferguson D, Seibel GL, Singh UC, Weiner P, Ollman PA. AMBER 4.1, 1995 University of California, San Francisco.
24. Case DA, Pearlman DA, Caldwell JW, Cheatham III TE, Ross WS, Simmerling CL, Darden TA, Merz KM, Stanton RV, Cheng AL, Vincent JJ, Crowley M, Ferguson DM, Radmer RJ, Seibel GL, Singh UC, Weiner PK, Kollman PA. AMBER 5, 1997. University of California, San Francisco.
25. Brooks B, Bruccoleri R, Olafson BO, States DJ, Swaminathan S, Karplus M. CHARMM a program for macromolecular energy minimization and dynamics calculations. Comp. Chem. 1983; 4: 187-217.
26. Brünger AT. The X-PLOR Software Manual, Version 3.1, 1992. Yale University Press: New Haven, CT.
27. Ripoll DR, Pottle MS, Gibson KD, Liwo A, Scheraga HA. Implementation of the ECEPP algorithm, the Monte Carlo minimization method. J. Comput. Chem. 1995; 16: 1153-1163.
28. Späth H. Cluster analysis algorithms. J. Comput. Chem. 1980; 10: 209-220.
29. 5]-enkephalin. J. Biomol. NMR 1999; 15: 315-330; http://www.tc.cornell.edu/resource/CompBiologyTools/analyze.
30. Massefski WJ, Bolton PH. Quantitative analysis of nuclear Overhauser effects. J. Magn. Reson. 1985; 65: 526-530.
31. Meadows RP, Post CB, Luxon BA, Gorenstein DG. MORASS 2.1, 1994. Purdue University, W. Lafayette.
32. Post CB, Meadows RP, Gorenstein DG. On the evaluation of interproton distance for 3-dimentional structure determination by NMR using a relaxation rate matrix analysis. J. Am. Chem. Soc. 1990; 112: 6796-6803.
33. Bystrov VF. Spin-spin coupling and the conformational states of peptide system. Progr. NMR Spectrosc. 1976; 10: 41-81.
34. Powell MJD. Restart procedures for conjugate gradient method program. Math. Prog. 1977; 12: 241-254.
35. Crisma M, Fasman GD, Balaram H, Balaram P. Peptide models for beta-turns. A circular dichroism study. Int. J. Pept. Protein Res. 1984; 23: 411-419.
36. Hollosi M, Kawai M, Fasman GD. Studies on proline-containing tetrapeptide models of beta-turns. Biopolymers 1985; 24: 211-242.
37. Topham CM, Mouledous L, Poda G, Maigret B, Meunier JC. Molecular modelling of the ORL1 receptor and its complex with nociceptin. Protein Eng. 1998; 11: 1163-1179.
38. Lapalu S, Moisand C, Mazarguil H, Cambois G, Mollereau C, Meunier JC. Comparison of the structure-activity relationship of nociceptin and dynorphin A using chimeric peptides. FEBS Lett. 1997; 417: 333-336.
39. Okada K, Sujaku T, Chuman Y, Nakashima R, Nose T, Costa T, Yamada Y, Yokoyama M, Nagahisa A, Shimohigashi Y. Highly potent nociceptin analogue containing the Arg-Lys triple repeat. Biochem. Biophys. Res. Commun. 2000; 278: 493-498.
40. Zhang C, Miller W, Valenzano KJ, Kyle DJ. Novel potent ORL-1 receptor agonist peptides containing α-helix promoting conformational constraints. J. Med. Chem. 2002; 45: 5280-5286.